posts rinri-therapeutics2023-05-01T12:31:57+00:00Stem cell therapy: a potential cure for hearing loss?rinri-therapeutics2023-05-01T12:31:57+00:00March 28, 2023|In the News|rinri-therapeutics2023-03-15T12:23:40+00:00Meet Doug Hartley, Chief Medical Officerrinri-therapeutics2023-03-15T12:23:40+00:00March 7, 2023|In the News, Personalities, Press releases|rinri-therapeutics2023-03-15T12:23:13+00:00Meet Gerry O’Donoghuerinri-therapeutics2023-03-15T12:23:13+00:00March 7, 2023|In the News, Personalities, Press releases|rinri-therapeutics2023-05-01T12:34:58+00:00Hearing Loss Therapies Made Possible by Unlocking Access to the Inner Earrinri-therapeutics2023-05-01T12:34:58+00:00January 9, 2023|In the News|rinri-therapeutics2023-05-01T12:40:27+00:00World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapiesrinri-therapeutics2023-05-01T12:40:27+00:00January 9, 2023|In the News, Press releases|rinri-therapeutics2023-05-01T12:44:42+00:00Self-assessment of cochlear health by cochlear implant recipients – published in Frontiers in Neurologyrinri-therapeutics2023-05-01T12:44:42+00:00January 9, 2023|In the News|rinri-therapeutics2023-05-01T12:47:29+00:00Unlocking the human inner ear for therapeutic intervention – published in Scientific Reportsrinri-therapeutics2023-05-01T12:47:29+00:00January 9, 2023|In the News|rinri-therapeutics2023-05-01T12:48:10+00:00International research coalition verifies safe surgical access to the central core of the human cochlea for the very first timerinri-therapeutics2023-05-01T12:48:10+00:00November 9, 2022|In the News, Press releases|rinri-therapeutics2023-05-01T12:48:45+00:00Restoring Natural Hearing Loss Using Cell Therapyrinri-therapeutics2023-05-01T12:48:45+00:00September 28, 2022|In the News, Perspectives|rinri-therapeutics2023-03-15T11:53:43+00:00Meet Terri Gaskell, Chief Technology Officerrinri-therapeutics2023-03-15T11:53:43+00:00September 28, 2022|In the News, Personalities, Press releases|rinri-therapeutics2023-03-15T11:54:04+00:00Meet Professor Marcelo Rivolta, Founder & Chief Scientific Officerrinri-therapeutics2023-03-15T11:54:04+00:00September 28, 2022|In the News, Personalities, Press releases|rinri-therapeutics2023-03-15T11:53:53+00:00Meet Simon Chandler, CEOrinri-therapeutics2023-03-15T11:53:53+00:00September 28, 2022|In the News, Personalities, Press releases|rinri-therapeutics2023-05-01T12:51:41+00:00Rinri attends 2nd Inner Ear Disorders Therapeutics Summitrinri-therapeutics2023-05-01T12:51:41+00:00June 20, 2022|In the News|rinri-therapeutics2023-05-01T12:52:27+00:00A cell therapy approach for hearing lossrinri-therapeutics2023-05-01T12:52:27+00:00June 13, 2022|In the News|rinri-therapeutics2023-05-01T12:53:36+00:00Rinri Therapeutics accelerates first regenerative cell therapy for hearing loss towards clinic with key senior hires and award of Innovation Passportrinri-therapeutics2023-05-01T12:53:36+00:00May 3, 2022|In the News, Press releases|rinri-therapeutics2023-05-01T12:54:13+00:00Rinri Therapeutics Secures Innovate UK Funding Grant for £3.2m Project to Advance its Novel Cell-Based Therapy to Restore Hearing Lossrinri-therapeutics2023-05-01T12:54:13+00:00May 13, 2021|In the News, Perspectives, Regulatory Press Releases|rinri-therapeutics2023-05-01T12:54:57+00:00Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Lossrinri-therapeutics2023-05-01T12:54:57+00:00April 20, 2021|In the News, Press releases, Regulatory Press Releases|rinri-therapeutics2023-02-17T09:29:37+00:00Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairmanrinri-therapeutics2023-02-17T09:29:37+00:00February 1, 2021|In the News, Personalities, Press releases|rinri-therapeutics2023-05-01T12:56:28+00:00Ground-breaking study to measure hearing healthrinri-therapeutics2023-05-01T12:56:28+00:00January 11, 2021|Press releases|rinri-therapeutics2023-03-15T11:54:15+00:00Rinri Therapeutics Appoints Terri Gaskell, PhD as Chief Technology Officerrinri-therapeutics2023-03-15T11:54:15+00:00December 17, 2020|In the News, Personalities, Press releases|rinri-therapeutics2023-05-01T13:11:07+00:00Regenerative medicine for hearing loss makes quiet progressrinri-therapeutics2023-05-01T13:11:07+00:00February 26, 2020|In the News|rinri-therapeutics2023-02-17T09:28:55+00:00Rinri announces the appointment of Dr. Natalie Mount as an independent non-executive directorrinri-therapeutics2023-02-17T09:28:55+00:00January 29, 2020|In the News, Personalities|rinri-therapeutics2023-05-01T13:08:30+00:00Sheffield start-up pioneering treatment to help the deaf hearrinri-therapeutics2023-05-01T13:08:30+00:00January 15, 2020|In the News|rinri-therapeutics2023-05-01T13:09:09+00:00LaBioTech – This Biotech Is Developing a Stem Cell Therapy for Deafnessrinri-therapeutics2023-05-01T13:09:09+00:00October 11, 2019|In the News|rinri-therapeutics2023-05-01T13:13:36+00:00Cures for Hearing Loss May Be Found in New Drugs. Researchers are trying to counter the biological causes of hearing loss, rather than just treating the effectsrinri-therapeutics2023-05-01T13:13:36+00:00September 15, 2019|In the News|rinri-therapeutics2023-05-01T13:18:48+00:00EuroBiotech: More Articles of Noterinri-therapeutics2023-05-01T13:18:48+00:00May 23, 2019|In the News|rinri-therapeutics2023-05-01T13:15:34+00:00Boehringer Doubles Down On Deafness With Rinri Backingrinri-therapeutics2023-05-01T13:15:34+00:00May 21, 2019|In the News|rinri-therapeutics2023-05-01T13:05:52+00:00Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinririnri-therapeutics2023-05-01T13:05:52+00:00May 20, 2019|In the News|rinri-therapeutics2023-05-01T12:57:13+00:00Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing lossrinri-therapeutics2023-05-01T12:57:13+00:00May 20, 2019|In the News, Press releases| rinri-therapeutics2022-11-09T16:45:57+00:00
rinri-therapeutics2023-05-01T12:31:57+00:00Stem cell therapy: a potential cure for hearing loss?rinri-therapeutics2023-05-01T12:31:57+00:00March 28, 2023|In the News|
rinri-therapeutics2023-03-15T12:23:40+00:00Meet Doug Hartley, Chief Medical Officerrinri-therapeutics2023-03-15T12:23:40+00:00March 7, 2023|In the News, Personalities, Press releases|
rinri-therapeutics2023-03-15T12:23:13+00:00Meet Gerry O’Donoghuerinri-therapeutics2023-03-15T12:23:13+00:00March 7, 2023|In the News, Personalities, Press releases|
rinri-therapeutics2023-05-01T12:34:58+00:00Hearing Loss Therapies Made Possible by Unlocking Access to the Inner Earrinri-therapeutics2023-05-01T12:34:58+00:00January 9, 2023|In the News|
rinri-therapeutics2023-05-01T12:40:27+00:00World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapiesrinri-therapeutics2023-05-01T12:40:27+00:00January 9, 2023|In the News, Press releases|
rinri-therapeutics2023-05-01T12:44:42+00:00Self-assessment of cochlear health by cochlear implant recipients – published in Frontiers in Neurologyrinri-therapeutics2023-05-01T12:44:42+00:00January 9, 2023|In the News|
rinri-therapeutics2023-05-01T12:47:29+00:00Unlocking the human inner ear for therapeutic intervention – published in Scientific Reportsrinri-therapeutics2023-05-01T12:47:29+00:00January 9, 2023|In the News|
rinri-therapeutics2023-05-01T12:48:10+00:00International research coalition verifies safe surgical access to the central core of the human cochlea for the very first timerinri-therapeutics2023-05-01T12:48:10+00:00November 9, 2022|In the News, Press releases|
rinri-therapeutics2023-05-01T12:48:45+00:00Restoring Natural Hearing Loss Using Cell Therapyrinri-therapeutics2023-05-01T12:48:45+00:00September 28, 2022|In the News, Perspectives|
rinri-therapeutics2023-03-15T11:53:43+00:00Meet Terri Gaskell, Chief Technology Officerrinri-therapeutics2023-03-15T11:53:43+00:00September 28, 2022|In the News, Personalities, Press releases|
rinri-therapeutics2023-03-15T11:54:04+00:00Meet Professor Marcelo Rivolta, Founder & Chief Scientific Officerrinri-therapeutics2023-03-15T11:54:04+00:00September 28, 2022|In the News, Personalities, Press releases|
rinri-therapeutics2023-03-15T11:53:53+00:00Meet Simon Chandler, CEOrinri-therapeutics2023-03-15T11:53:53+00:00September 28, 2022|In the News, Personalities, Press releases|
rinri-therapeutics2023-05-01T12:51:41+00:00Rinri attends 2nd Inner Ear Disorders Therapeutics Summitrinri-therapeutics2023-05-01T12:51:41+00:00June 20, 2022|In the News|
rinri-therapeutics2023-05-01T12:52:27+00:00A cell therapy approach for hearing lossrinri-therapeutics2023-05-01T12:52:27+00:00June 13, 2022|In the News|
rinri-therapeutics2023-05-01T12:53:36+00:00Rinri Therapeutics accelerates first regenerative cell therapy for hearing loss towards clinic with key senior hires and award of Innovation Passportrinri-therapeutics2023-05-01T12:53:36+00:00May 3, 2022|In the News, Press releases|
rinri-therapeutics2023-05-01T12:54:13+00:00Rinri Therapeutics Secures Innovate UK Funding Grant for £3.2m Project to Advance its Novel Cell-Based Therapy to Restore Hearing Lossrinri-therapeutics2023-05-01T12:54:13+00:00May 13, 2021|In the News, Perspectives, Regulatory Press Releases|
rinri-therapeutics2023-05-01T12:54:57+00:00Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Lossrinri-therapeutics2023-05-01T12:54:57+00:00April 20, 2021|In the News, Press releases, Regulatory Press Releases|
rinri-therapeutics2023-02-17T09:29:37+00:00Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairmanrinri-therapeutics2023-02-17T09:29:37+00:00February 1, 2021|In the News, Personalities, Press releases|
rinri-therapeutics2023-05-01T12:56:28+00:00Ground-breaking study to measure hearing healthrinri-therapeutics2023-05-01T12:56:28+00:00January 11, 2021|Press releases|
rinri-therapeutics2023-03-15T11:54:15+00:00Rinri Therapeutics Appoints Terri Gaskell, PhD as Chief Technology Officerrinri-therapeutics2023-03-15T11:54:15+00:00December 17, 2020|In the News, Personalities, Press releases|
rinri-therapeutics2023-05-01T13:11:07+00:00Regenerative medicine for hearing loss makes quiet progressrinri-therapeutics2023-05-01T13:11:07+00:00February 26, 2020|In the News|
rinri-therapeutics2023-02-17T09:28:55+00:00Rinri announces the appointment of Dr. Natalie Mount as an independent non-executive directorrinri-therapeutics2023-02-17T09:28:55+00:00January 29, 2020|In the News, Personalities|
rinri-therapeutics2023-05-01T13:08:30+00:00Sheffield start-up pioneering treatment to help the deaf hearrinri-therapeutics2023-05-01T13:08:30+00:00January 15, 2020|In the News|
rinri-therapeutics2023-05-01T13:09:09+00:00LaBioTech – This Biotech Is Developing a Stem Cell Therapy for Deafnessrinri-therapeutics2023-05-01T13:09:09+00:00October 11, 2019|In the News|
rinri-therapeutics2023-05-01T13:13:36+00:00Cures for Hearing Loss May Be Found in New Drugs. Researchers are trying to counter the biological causes of hearing loss, rather than just treating the effectsrinri-therapeutics2023-05-01T13:13:36+00:00September 15, 2019|In the News|
rinri-therapeutics2023-05-01T13:18:48+00:00EuroBiotech: More Articles of Noterinri-therapeutics2023-05-01T13:18:48+00:00May 23, 2019|In the News|
rinri-therapeutics2023-05-01T13:15:34+00:00Boehringer Doubles Down On Deafness With Rinri Backingrinri-therapeutics2023-05-01T13:15:34+00:00May 21, 2019|In the News|
rinri-therapeutics2023-05-01T13:05:52+00:00Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinririnri-therapeutics2023-05-01T13:05:52+00:00May 20, 2019|In the News|
rinri-therapeutics2023-05-01T12:57:13+00:00Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing lossrinri-therapeutics2023-05-01T12:57:13+00:00May 20, 2019|In the News, Press releases|
